 | • レポートコード：QYR2104Z0361 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品、ヘルスケア |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、抗ニキビ薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（OTC、処方薬）、用途別市場規模（局所、経口）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・抗ニキビ薬の市場動向 ・企業の競争状況、市場シェア ・抗ニキビ薬の種類別市場規模（OTC、処方薬） ・抗ニキビ薬の用途別市場規模（局所、経口） ・抗ニキビ薬の北米市場規模2016-2027（アメリカ、カナダ） ・抗ニキビ薬のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・抗ニキビ薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・抗ニキビ薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・抗ニキビ薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Galderma、Bausch Health、Teva、GlaxoSmithKline、Mylan、Almirall、Sun Pharma、Mayne Pharma、Lion、HUAPONT、Sine Pharma） ・結論 |
Acne, also known as acne vulgaris, is a long-term skin condition that occurs when dead skin cells and oil from the skin clog hair follicles. Typical features of the condition include blackheads or whiteheads, pimples, oily skin, and possible scarring. It primarily affects skin with a relatively high number of oil glands, including the face, upper part of the chest, and back. The resulting appearance can lead to anxiety, reduced self-esteem, and, in extreme cases, depression or thoughts of suicide.
Market Analysis and Insights: Global Anti Ance Drug Market
The global Anti Ance Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Anti Ance Drug market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Anti Ance Drug market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Anti Ance Drug market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Anti Ance Drug market.
Global Anti Ance Drug Scope and Market Size
Anti Ance Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Anti Ance Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
OTC
Prescription Medicine
Segment by Application
Topical
Oral
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Galderma
Bausch Health
Teva
GlaxoSmithKline
Mylan
Almirall
Sun Pharma
Mayne Pharma
Lion
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Anti Ance Drug Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 OTC
1.2.3 Prescription Medicine
1.3 Market by Application
1.3.1 Global Anti Ance Drug Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Topical
1.3.3 Oral
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Anti Ance Drug Market Perspective (2016-2027)
2.2 Anti Ance Drug Growth Trends by Regions
2.2.1 Anti Ance Drug Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Anti Ance Drug Historic Market Share by Regions (2016-2021)
2.2.3 Anti Ance Drug Forecasted Market Size by Regions (2022-2027)
2.3 Anti Ance Drug Industry Dynamic
2.3.1 Anti Ance Drug Market Trends
2.3.2 Anti Ance Drug Market Drivers
2.3.3 Anti Ance Drug Market Challenges
2.3.4 Anti Ance Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Anti Ance Drug Players by Revenue
3.1.1 Global Top Anti Ance Drug Players by Revenue (2016-2021)
3.1.2 Global Anti Ance Drug Revenue Market Share by Players (2016-2021)
3.2 Global Anti Ance Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Anti Ance Drug Revenue
3.4 Global Anti Ance Drug Market Concentration Ratio
3.4.1 Global Anti Ance Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Anti Ance Drug Revenue in 2020
3.5 Anti Ance Drug Key Players Head office and Area Served
3.6 Key Players Anti Ance Drug Product Solution and Service
3.7 Date of Enter into Anti Ance Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Anti Ance Drug Breakdown Data by Type
4.1 Global Anti Ance Drug Historic Market Size by Type (2016-2021)
4.2 Global Anti Ance Drug Forecasted Market Size by Type (2022-2027)
5 Anti Ance Drug Breakdown Data by Application
5.1 Global Anti Ance Drug Historic Market Size by Application (2016-2021)
5.2 Global Anti Ance Drug Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Anti Ance Drug Market Size (2016-2027)
6.2 North America Anti Ance Drug Market Size by Type
6.2.1 North America Anti Ance Drug Market Size by Type (2016-2021)
6.2.2 North America Anti Ance Drug Market Size by Type (2022-2027)
6.2.3 North America Anti Ance Drug Market Size by Type (2016-2027)
6.3 North America Anti Ance Drug Market Size by Application
6.3.1 North America Anti Ance Drug Market Size by Application (2016-2021)
6.3.2 North America Anti Ance Drug Market Size by Application (2022-2027)
6.3.3 North America Anti Ance Drug Market Size by Application (2016-2027)
6.4 North America Anti Ance Drug Market Size by Country
6.4.1 North America Anti Ance Drug Market Size by Country (2016-2021)
6.4.2 North America Anti Ance Drug Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Anti Ance Drug Market Size (2016-2027)
7.2 Europe Anti Ance Drug Market Size by Type
7.2.1 Europe Anti Ance Drug Market Size by Type (2016-2021)
7.2.2 Europe Anti Ance Drug Market Size by Type (2022-2027)
7.2.3 Europe Anti Ance Drug Market Size by Type (2016-2027)
7.3 Europe Anti Ance Drug Market Size by Application
7.3.1 Europe Anti Ance Drug Market Size by Application (2016-2021)
7.3.2 Europe Anti Ance Drug Market Size by Application (2022-2027)
7.3.3 Europe Anti Ance Drug Market Size by Application (2016-2027)
7.4 Europe Anti Ance Drug Market Size by Country
7.4.1 Europe Anti Ance Drug Market Size by Country (2016-2021)
7.4.2 Europe Anti Ance Drug Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Anti Ance Drug Market Size (2016-2027)
8.2 Asia-Pacific Anti Ance Drug Market Size by Type
8.2.1 Asia-Pacific Anti Ance Drug Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Anti Ance Drug Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Anti Ance Drug Market Size by Type (2016-2027)
8.3 Asia-Pacific Anti Ance Drug Market Size by Application
8.3.1 Asia-Pacific Anti Ance Drug Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Anti Ance Drug Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Anti Ance Drug Market Size by Application (2016-2027)
8.4 Asia-Pacific Anti Ance Drug Market Size by Region
8.4.1 Asia-Pacific Anti Ance Drug Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Anti Ance Drug Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Anti Ance Drug Market Size (2016-2027)
9.2 Latin America Anti Ance Drug Market Size by Type
9.2.1 Latin America Anti Ance Drug Market Size by Type (2016-2021)
9.2.2 Latin America Anti Ance Drug Market Size by Type (2022-2027)
9.2.3 Latin America Anti Ance Drug Market Size by Type (2016-2027)
9.3 Latin America Anti Ance Drug Market Size by Application
9.3.1 Latin America Anti Ance Drug Market Size by Application (2016-2021)
9.3.2 Latin America Anti Ance Drug Market Size by Application (2022-2027)
9.3.3 Latin America Anti Ance Drug Market Size by Application (2016-2027)
9.4 Latin America Anti Ance Drug Market Size by Country
9.4.1 Latin America Anti Ance Drug Market Size by Country (2016-2021)
9.4.2 Latin America Anti Ance Drug Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Anti Ance Drug Market Size (2016-2027)
10.2 Middle East & Africa Anti Ance Drug Market Size by Type
10.2.1 Middle East & Africa Anti Ance Drug Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Anti Ance Drug Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Anti Ance Drug Market Size by Type (2016-2027)
10.3 Middle East & Africa Anti Ance Drug Market Size by Application
10.3.1 Middle East & Africa Anti Ance Drug Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Anti Ance Drug Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Anti Ance Drug Market Size by Application (2016-2027)
10.4 Middle East & Africa Anti Ance Drug Market Size by Country
10.4.1 Middle East & Africa Anti Ance Drug Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Anti Ance Drug Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Galderma
11.1.1 Galderma Company Details
11.1.2 Galderma Business Overview
11.1.3 Galderma Anti Ance Drug Introduction
11.1.4 Galderma Revenue in Anti Ance Drug Business (2016-2021)
11.1.5 Galderma Recent Development
11.2 Bausch Health
11.2.1 Bausch Health Company Details
11.2.2 Bausch Health Business Overview
11.2.3 Bausch Health Anti Ance Drug Introduction
11.2.4 Bausch Health Revenue in Anti Ance Drug Business (2016-2021)
11.2.5 Bausch Health Recent Development
11.3 Teva
11.3.1 Teva Company Details
11.3.2 Teva Business Overview
11.3.3 Teva Anti Ance Drug Introduction
11.3.4 Teva Revenue in Anti Ance Drug Business (2016-2021)
11.3.5 Teva Recent Development
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Company Details
11.4.2 GlaxoSmithKline Business Overview
11.4.3 GlaxoSmithKline Anti Ance Drug Introduction
11.4.4 GlaxoSmithKline Revenue in Anti Ance Drug Business (2016-2021)
11.4.5 GlaxoSmithKline Recent Development
11.5 Mylan
11.5.1 Mylan Company Details
11.5.2 Mylan Business Overview
11.5.3 Mylan Anti Ance Drug Introduction
11.5.4 Mylan Revenue in Anti Ance Drug Business (2016-2021)
11.5.5 Mylan Recent Development
11.6 Almirall
11.6.1 Almirall Company Details
11.6.2 Almirall Business Overview
11.6.3 Almirall Anti Ance Drug Introduction
11.6.4 Almirall Revenue in Anti Ance Drug Business (2016-2021)
11.6.5 Almirall Recent Development
11.7 Sun Pharma
11.7.1 Sun Pharma Company Details
11.7.2 Sun Pharma Business Overview
11.7.3 Sun Pharma Anti Ance Drug Introduction
11.7.4 Sun Pharma Revenue in Anti Ance Drug Business (2016-2021)
11.7.5 Sun Pharma Recent Development
11.8 Mayne Pharma
11.8.1 Mayne Pharma Company Details
11.8.2 Mayne Pharma Business Overview
11.8.3 Mayne Pharma Anti Ance Drug Introduction
11.8.4 Mayne Pharma Revenue in Anti Ance Drug Business (2016-2021)
11.8.5 Mayne Pharma Recent Development
11.9 Lion
11.9.1 Lion Company Details
11.9.2 Lion Business Overview
11.9.3 Lion Anti Ance Drug Introduction
11.9.4 Lion Revenue in Anti Ance Drug Business (2016-2021)
11.9.5 Lion Recent Development
11.10 HUAPONT
11.10.1 HUAPONT Company Details
11.10.2 HUAPONT Business Overview
11.10.3 HUAPONT Anti Ance Drug Introduction
11.10.4 HUAPONT Revenue in Anti Ance Drug Business (2016-2021)
11.10.5 HUAPONT Recent Development
11.11 Sine Pharma
11.11.1 Sine Pharma Company Details
11.11.2 Sine Pharma Business Overview
11.11.3 Sine Pharma Anti Ance Drug Introduction
11.11.4 Sine Pharma Revenue in Anti Ance Drug Business (2016-2021)
11.11.5 Sine Pharma Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Anti Ance Drug Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of OTC
Table 3. Key Players of Prescription Medicine
Table 4. Global Anti Ance Drug Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Anti Ance Drug Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Anti Ance Drug Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Anti Ance Drug Market Share by Regions (2016-2021)
Table 8. Global Anti Ance Drug Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Anti Ance Drug Market Share by Regions (2022-2027)
Table 10. Anti Ance Drug Market Trends
Table 11. Anti Ance Drug Market Drivers
Table 12. Anti Ance Drug Market Challenges
Table 13. Anti Ance Drug Market Restraints
Table 14. Global Anti Ance Drug Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Anti Ance Drug Market Share by Players (2016-2021)
Table 16. Global Top Anti Ance Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti Ance Drug as of 2020)
Table 17. Ranking of Global Top Anti Ance Drug Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Anti Ance Drug Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Anti Ance Drug Product Solution and Service
Table 21. Date of Enter into Anti Ance Drug Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Anti Ance Drug Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Anti Ance Drug Revenue Market Share by Type (2016-2021)
Table 25. Global Anti Ance Drug Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Anti Ance Drug Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Anti Ance Drug Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Anti Ance Drug Revenue Market Share by Application (2016-2021)
Table 29. Global Anti Ance Drug Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Anti Ance Drug Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Anti Ance Drug Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Anti Ance Drug Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Anti Ance Drug Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Anti Ance Drug Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Anti Ance Drug Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Anti Ance Drug Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Anti Ance Drug Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Anti Ance Drug Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Anti Ance Drug Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Anti Ance Drug Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Anti Ance Drug Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Anti Ance Drug Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Anti Ance Drug Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Anti Ance Drug Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Anti Ance Drug Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Anti Ance Drug Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Anti Ance Drug Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Anti Ance Drug Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Anti Ance Drug Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Anti Ance Drug Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Anti Ance Drug Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Anti Ance Drug Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Anti Ance Drug Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Anti Ance Drug Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Anti Ance Drug Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Anti Ance Drug Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Anti Ance Drug Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Anti Ance Drug Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Anti Ance Drug Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Anti Ance Drug Market Size by Country (2022-2027) & (US$ Million)
Table 61. Galderma Company Details
Table 62. Galderma Business Overview
Table 63. Galderma Anti Ance Drug Product
Table 64. Galderma Revenue in Anti Ance Drug Business (2016-2021) & (US$ Million)
Table 65. Galderma Recent Development
Table 66. Bausch Health Company Details
Table 67. Bausch Health Business Overview
Table 68. Bausch Health Anti Ance Drug Product
Table 69. Bausch Health Revenue in Anti Ance Drug Business (2016-2021) & (US$ Million)
Table 70. Bausch Health Recent Development
Table 71. Teva Company Details
Table 72. Teva Business Overview
Table 73. Teva Anti Ance Drug Product
Table 74. Teva Revenue in Anti Ance Drug Business (2016-2021) & (US$ Million)
Table 75. Teva Recent Development
Table 76. GlaxoSmithKline Company Details
Table 77. GlaxoSmithKline Business Overview
Table 78. GlaxoSmithKline Anti Ance Drug Product
Table 79. GlaxoSmithKline Revenue in Anti Ance Drug Business (2016-2021) & (US$ Million)
Table 80. GlaxoSmithKline Recent Development
Table 81. Mylan Company Details
Table 82. Mylan Business Overview
Table 83. Mylan Anti Ance Drug Product
Table 84. Mylan Revenue in Anti Ance Drug Business (2016-2021) & (US$ Million)
Table 85. Mylan Recent Development
Table 86. Almirall Company Details
Table 87. Almirall Business Overview
Table 88. Almirall Anti Ance Drug Product
Table 89. Almirall Revenue in Anti Ance Drug Business (2016-2021) & (US$ Million)
Table 90. Almirall Recent Development
Table 91. Sun Pharma Company Details
Table 92. Sun Pharma Business Overview
Table 93. Sun Pharma Anti Ance Drug Product
Table 94. Sun Pharma Revenue in Anti Ance Drug Business (2016-2021) & (US$ Million)
Table 95. Sun Pharma Recent Development
Table 96. Mayne Pharma Company Details
Table 97. Mayne Pharma Business Overview
Table 98. Mayne Pharma Revenue in Anti Ance Drug Business (2016-2021) & (US$ Million)
Table 99. Mayne Pharma Recent Development
Table 100. Lion Company Details
Table 101. Lion Business Overview
Table 102. Lion Anti Ance Drug Product
Table 103. Lion Revenue in Anti Ance Drug Business (2016-2021) & (US$ Million)
Table 104. Lion Recent Development
Table 105. HUAPONT Company Details
Table 106. HUAPONT Business Overview
Table 107. HUAPONT Anti Ance Drug Product
Table 108. HUAPONT Revenue in Anti Ance Drug Business (2016-2021) & (US$ Million)
Table 109. HUAPONT Recent Development
Table 110. Sine Pharma Company Details
Table 111. Sine Pharma Business Overview
Table 112. Sine Pharma Anti Ance Drug Product
Table 113. Sine Pharma Revenue in Anti Ance Drug Business (2016-2021) & (US$ Million)
Table 114. Sine Pharma Recent Development
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Anti Ance Drug Market Share by Type: 2020 VS 2027
Figure 2. OTC Features
Figure 3. Prescription Medicine Features
Figure 4. Global Anti Ance Drug Market Share by Application: 2020 VS 2027
Figure 5. Topical Case Studies
Figure 6. Oral Case Studies
Figure 7. Anti Ance Drug Report Years Considered
Figure 8. Global Anti Ance Drug Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 9. Global Anti Ance Drug Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Anti Ance Drug Market Share by Regions: 2020 VS 2027
Figure 11. Global Anti Ance Drug Market Share by Regions (2022-2027)
Figure 12. Global Anti Ance Drug Market Share by Players in 2020
Figure 13. Global Top Anti Ance Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti Ance Drug as of 2020
Figure 14. The Top 10 and 5 Players Market Share by Anti Ance Drug Revenue in 2020
Figure 15. Global Anti Ance Drug Revenue Market Share by Type (2016-2021)
Figure 16. Global Anti Ance Drug Revenue Market Share by Type (2022-2027)
Figure 17. North America Anti Ance Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 18. North America Anti Ance Drug Market Share by Type (2016-2027)
Figure 19. North America Anti Ance Drug Market Share by Application (2016-2027)
Figure 20. North America Anti Ance Drug Market Share by Country (2016-2027)
Figure 21. United States Anti Ance Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. Canada Anti Ance Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Europe Anti Ance Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Anti Ance Drug Market Share by Type (2016-2027)
Figure 25. Europe Anti Ance Drug Market Share by Application (2016-2027)
Figure 26. Europe Anti Ance Drug Market Share by Country (2016-2027)
Figure 27. Germany Anti Ance Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. France Anti Ance Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. U.K. Anti Ance Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Italy Anti Ance Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Russia Anti Ance Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Nordic Anti Ance Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Asia-Pacific Anti Ance Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Anti Ance Drug Market Share by Type (2016-2027)
Figure 35. Asia-Pacific Anti Ance Drug Market Share by Application (2016-2027)
Figure 36. Asia-Pacific Anti Ance Drug Market Share by Region (2016-2027)
Figure 37. China Anti Ance Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Japan Anti Ance Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. South Korea Anti Ance Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Southeast Asia Anti Ance Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. India Anti Ance Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Australia Anti Ance Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Latin America Anti Ance Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Anti Ance Drug Market Share by Type (2016-2027)
Figure 45. Latin America Anti Ance Drug Market Share by Application (2016-2027)
Figure 46. Latin America Anti Ance Drug Market Share by Country (2016-2027)
Figure 47. Mexico Anti Ance Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Brazil Anti Ance Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Middle East & Africa Anti Ance Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Anti Ance Drug Market Share by Type (2016-2027)
Figure 51. Middle East & Africa Anti Ance Drug Market Share by Application (2016-2027)
Figure 52. Middle East & Africa Anti Ance Drug Market Share by Country (2016-2027)
Figure 53. Turkey Anti Ance Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Saudi Arabia Anti Ance Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. UAE Anti Ance Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Galderma Revenue Growth Rate in Anti Ance Drug Business (2016-2021)
Figure 57. Bausch Health Revenue Growth Rate in Anti Ance Drug Business (2016-2021)
Figure 58. Teva Revenue Growth Rate in Anti Ance Drug Business (2016-2021)
Figure 59. GlaxoSmithKline Revenue Growth Rate in Anti Ance Drug Business (2016-2021)
Figure 60. Mylan Revenue Growth Rate in Anti Ance Drug Business (2016-2021)
Figure 61. Almirall Revenue Growth Rate in Anti Ance Drug Business (2016-2021)
Figure 62. Sun Pharma Revenue Growth Rate in Anti Ance Drug Business (2016-2021)
Figure 63. Mayne Pharma Revenue Growth Rate in Anti Ance Drug Business (2016-2021)
Figure 64. Lion Revenue Growth Rate in Anti Ance Drug Business (2016-2021)
Figure 65. HUAPONT Revenue Growth Rate in Anti Ance Drug Business (2016-2021)
Figure 66. Sine Pharma Revenue Growth Rate in Anti Ance Drug Business (2016-2021)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
世界の抗口腔粘膜炎薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Anti–Oral Mucositis Drug Market The global Anti–Oral Mucositis Drug market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the …- 世界の抗口腔粘膜炎薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Anti–Oral Mucositis Drug Market The global Anti–Oral Mucositis Drug market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the …
- 世界の抗緑内障薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Anti-glaucoma Drug Market The global Anti-glaucoma Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report makes…
- 世界の抗緑内障薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Anti-glaucoma Drug Market The global Anti-glaucoma Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report makes…
- 世界の抗腫瘍薬市場規模・現状・予測（2021年-2027年） Anti-tumor drugs are for the treatment of cancer diseases. In recent years, the development of molecular oncology and molecular pharmacology has gradually clarified the nature of the tumor. The invention and application of advanced technologies such as large-scale rapid screening, combinatorial chem…